摘要
观察柴胡合剂抗肝纤维化作用。选择慢性活动性肝炎、早期肝硬化病人20例,柴胡合剂9g/次,每日3次口服,服药时间平均(8±3)个月。初步临床观察发现,柴胡合剂具有降低患者血清转氨酶及提高白蛋白水平的作用,同时能明显降低血清透明质酸及血清Ⅲ型前胶原水平,使肿大的肝脾回缩趋于正常,初步表明柴胡合剂有良好的改善肝功能及抗肝纤维化作用。
The effects of compound Bupleurum mixture (CBM) were investigated on liver fibrosix of 20 cases with chronic active hepatitis or early cirrhosis. CBM were given orally,the dosage was 9g× 3 per day for 6~12 months mean (8± 3)months. The results were as follows;all patients liver function improved significantly than before treatment (P<0. 05). The levels of serum procollagen Ⅲ type (PCⅢ) and hyaluronic acid(HA)were -significantly lower than before treatment(P<0. 05). These results suggested that CBM could improve liver function and inhibit the formation of fibrosis in early liver cirrhosis and chronic active hepatitis.
出处
《天津医药》
CAS
1997年第11期665-666,共2页
Tianjin Medical Journal
关键词
柴胡合剂
抗肝纤维化
肝硬化
中医药疗法
Bupleurum liver function hyaluronic acid PCⅢ early liver cirrhosis chronic active hepatitis
